Fume Hood Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 604.03 Million |
| Market Size (2029) | USD 747.74 Million |
| CAGR (2024 - 2029) | 4.36 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Fume Hood Market Analysis
The Fume Hood Market size is estimated at USD 604.03 million in 2024, and is expected to reach USD 747.74 million by 2029, growing at a CAGR of 4.36% during the forecast period (2024-2029).
The COVID-19 pandemic had a significant impact on the market. Due to the pandemic, many pharmaceutical companies increased their R&D capacities, which led to the development of more laboratories worldwide. With the increasing number of laboratories, the adoption of fume hoods also increased. For instance, in October 2022, BioNTech SE announced its plans to set up research and manufacturing centers in Australia based on the same technology used to develop the mRNA COVID-19 vaccine. The company and Australia's Victoria state signed a partnership to create a center to conduct clinical research on experimental messenger ribonucleic acid, mRNA, vaccines, and therapies to attract experts worldwide. Such R&D initiatives by various market players boosted the adoption of fume hoods in laboratories. Hence, the COVID-19 pandemic impacted the growth of the market significantly. However, with the pandemic subsiding, the studied market is expected to have stable growth over the forecast period.
Factors such as the rising safety measures of the laboratory by government and private organizations and the increasing investments to develop pharmaceutical laboratory infrastructures are the major factors driving the market's growth. With the increasing demand for developing medicines, the pharmaceutical and biopharmaceutical industry is constantly showing a significant contribution, which is expected to propel the fume hood market.
The increasing prevalence of various chronic and infectious diseases across the world is expected to boost the R&D processes of pharmaceutical companies, which may ultimately lead to increased adoption of fume hoods in research laboratories. For instance, according to the report published by the Chinese Medical Journal in March 2022, China is experiencing a greater incidence of cancers. In 2022, there were approximately 4,820,000 new cancer cases in China, with the most common being lung cancer.
According to the data published by the Korea Disease Control and Prevention Agency in December 2022, in week 48 of 2022, the overall weekly influenza-like illness (ILI) rate was 15.0%, higher than the 13.9% recorded in the previous week in South Korea. It was also reported that in week 48 of 2022, out of the 271 respiratory specimens, 20 samples (7.4%) were positive for the influenza virus. Hence, the increasing prevalence of such chronic and infectious diseases is expected to increase the expenditure of pharmaceutical companies in R&D, which may lead to increased adoption of fume hoods in their R&D laboratories.
Hence, the increasing prevalence of chronic and infectious diseases is expected to boost the market's growth. However, the high instrument cost is expected to restrict the growth of the fume hood market in the future.
Fume Hood Market Trends
Ductless Fume Hood Segment is Expected to Hold Significant Market Share During the Forecast Period
A ductless fume hood is an alternative to conventional fume hoods. This type of fume hood utilizes carbon or HEPA filtration to protect laboratory personnel from toxic chemical fumes, odors, and particles. It has several advantages over duct fume hoods, such as a plug-and-play feature, mobility, hassle-free installation, and no lab work interruption.
The increasing advantages of ductless fume hoods and the rising prevalence of chronic and infectious diseases worldwide are the major factors driving the segment's growth. For instance, according to a blog post published by Kewaunee International Group, a manufacturer of fume hoods, in August 2022, ductless fume hoods have several advantages over duct fume hoods, such as easy installation and mobility, less energy used, and significantly cheaper compared to ducted variants.
The increasing prevalence of chronic and infectious diseases across the world is expected to increase the expenditure by pharmaceutical companies on R&D, leading to the adoption of technologically advanced products such as ductless fume hoods in research laboratories. For instance, according to the data published by the National Cancer Center Japan in June 2022, an estimated 1,019,000 new cases of cancer were recorded in Japan in 2022, out of which 158,200 were new cases of colon/rectum cancer, 132,100 were stomach cancer cases, 128,800 were lung/trachea cancer cases, 96,400 were prostate cancer cases, and 95,000 were breast cancer cases.
According to data published by the WHO in October 2022, an estimated 227,153 specimens were processed for testing influenza in Australia in 2022, and 11,382 specimens were found to be positive. Thus, the rising prevalence of diseases such as influenza and HIV is expected to boost the R&D activities of pharmaceutical companies, which may boost the adoption of technologically advanced products such as ductless fume hoods in R&D laboratories.
North America is Expected to Hold Significant Share in the Market During the Forecast Period
North America is expected to have a significant share in the fume hood market, owing to technologically advanced products and the increasing burden of occupational, chronic, and infectious diseases.
According to the data updated by the Asthma and Allergy Foundation of America in April 2022, approximately 25 million people in the United States have asthma, equalling about 1 in 13 people, and about 20 million US people aged 18 and older have asthma. Hence, the high prevalence of chronic diseases like asthma in the United States is expected to increase the adoption of fume hoods in laboratories.
The rising prevalence of chronic diseases like cancer is also expected to boost the R&D expenditure of pharmaceutical companies, leading to the increasing adoption of fume hoods in research laboratories. For instance, according to the report published by the American Cancer Society in 2022, an estimated 1.9 million new cancer cases were diagnosed in the United States in 2022. According to the Canadian Cancer Society data published in November 2022, 233,900 people were to be diagnosed with cancer in 2022. This growing incidence is largely due to Canada's growing and aging population and emphasizes the importance of cancer prevention.
Hence, the fume hood market is expected to grow in North America due to the development of technologically advanced products and the increasing burden of occupational, chronic, and infectious diseases.
Fume Hood Industry Overview
The fume hood market is fragmented and consists of several major players. Companies are adopting growth strategies to increase their presence in the market. In terms of market share, a few of the major players are currently dominating the market, including Waldner Inc., Labconco Corporation, ThermoFisher Scientific, Airclean Systems Inc., Hemco Corporation, NuAire, Erlab, Flow Science Inc., and Air Science.
Fume Hood Market Leaders
-
Flow Sciences, Inc.
-
ThermoFisher Scientific
-
NuAire
-
Hemco Corporation
-
Erlab
*Disclaimer: Major Players sorted in no particular order
Fume Hood Market News
- In October 2022, Air Science launched the Purair FLOW Mycology Hood. This new hood creates a sterile environment on the work surface for mushroom cultures.
- In September 2022, Hemco launched its new UniFlow radioisotope fume hood for lab work involving radiochemicals. The product is constructed with a welded one-piece seamless type 304 stainless steel interior fume chamber with all corners coved for easy cleaning.
Fume Hood Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Safety Measures in Laboratories by Government and Private Organizations
4.2.2 Increasing Investments to Develop Pharmaceutical Laboratory Infrastructure
4.3 Market Restraints
4.3.1 High Cost of Instruments
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value USD million)
5.1 By Product Type
5.1.1 Duct Fume Hood
5.1.2 Duct-less Fume Hood
5.1.3 Accessories
5.2 By Mobility
5.2.1 Bench-top
5.2.2 Mobile
5.3 By Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Air Science
6.1.2 Airclean Systems Inc.
6.1.3 Erlab
6.1.4 Flow Sciences Inc.
6.1.5 Hemco Corporation
6.1.6 Labconco Corporation
6.1.7 NuAire
6.1.8 ThermoFisher Scientific
6.1.9 Thomas Scientific
6.1.10 Waldner Inc.
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Fume Hood Industry Segmentation
As per the scope of the report, a fume hood is a ventilator device built for performing hazardous experiments by drawing toxic air through ducts or filters.
The fume hood market is projected to record a CAGR of 2.8% during the forecast period. The fume hood market is segmented by product type (duct fume hood, ductless fume hood, and accessories), mobility (bench-top and mobile), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.
| By Product Type | |
| Duct Fume Hood | |
| Duct-less Fume Hood | |
| Accessories |
| By Mobility | |
| Bench-top | |
| Mobile |
| By Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Fume Hood Market Research FAQs
How big is the Fume Hood Market?
The Fume Hood Market size is expected to reach USD 604.03 million in 2024 and grow at a CAGR of 4.36% to reach USD 747.74 million by 2029.
What is the current Fume Hood Market size?
In 2024, the Fume Hood Market size is expected to reach USD 604.03 million.
Who are the key players in Fume Hood Market?
Flow Sciences, Inc., ThermoFisher Scientific, NuAire, Hemco Corporation and Erlab are the major companies operating in the Fume Hood Market.
Which is the fastest growing region in Fume Hood Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Fume Hood Market?
In 2024, the North America accounts for the largest market share in Fume Hood Market.
What years does this Fume Hood Market cover, and what was the market size in 2023?
In 2023, the Fume Hood Market size was estimated at USD 577.69 million. The report covers the Fume Hood Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Fume Hood Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Hyaluronidase Industry Report
Statistics for the 2024 Hyaluronidase market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Hyaluronidase analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
